Laura K. Shawver
Net Worth

Last updated:

What is Laura K. Shawver net worth?

The estimated net worth of Dr. Laura K. Shawver is at least $7,184,954 as of 1 Sep 2023. He owns shares worth $1,234,731 as insider, has earned $3,590,273 from insider trading and has received compensation worth at least $2,359,950 in Silverback Therapeutics, Inc..

What is the salary of Laura K. Shawver?

Dr. Laura K. Shawver salary is $786,650 per year as Chief Executive Officer & Director in Silverback Therapeutics, Inc..

How old is Laura K. Shawver?

Dr. Laura K. Shawver is 67 years old, born in 1958.

What stocks does Laura K. Shawver currently own?

As insider, Dr. Laura K. Shawver owns shares in one company:

Company Title Shares Price per share Total value
Silverback Therapeutics, Inc. (SBTX) Chief Executive Officer & Director 210,346 $5.87 $1,234,731

What does Silverback Therapeutics, Inc. do?

Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

SBTX logo
SBTX
Silverback Therapeutics, Inc.
$5.87

Laura K. Shawver insider trading

Silverback Therapeutics, Inc.

Dr. Laura K. Shawver has made 14 insider trades between 2022-2023, according to the Form 4 filled with the SEC. Most recently he sold 100,000 units of SBTX stock worth $770,500 on 1 Sep 2023.

The largest trade he's ever made was exercising 100,000 units of SBTX stock on 1 Sep 2023. As of 1 Sep 2023 he still owns at least 210,346 units of SBTX stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 100,000 $7.71 $770,500
Option
Common Stock 97,003 $1.27 $123,194
Option
Common Stock 2,997 $1.27 $3,806
Option
Stock Option (Right to Buy) 2,997 $1.27 $3,806
Option
Stock Option (Right to Buy) 97,003 $1.27 $123,194
Sale
Common Stock 18,897 $7.06 $133,470
Option
Stock Option (Right to Buy) 18,897 $1.27 $23,999
Option
Common Stock 18,897 $1.27 $23,999
Sale
Common Stock 26,107 $7.01 $183,010
Option
Stock Option (Right to Buy) 26,017 $1.27 $33,042
Option
Common Stock 26,107 $1.27 $33,156
Option
Stock Option (Right to Buy) 36,281 $1.27 $46,077
Sale
Common Stock 36,281 $7.09 $257,269
Option
Common Stock 36,281 $1.27 $46,077
Option
Common Stock 18,715 $1.27 $23,768
Sale
Common Stock 18,715 $7.19 $134,580
Option
Stock Option (Right to Buy) 18,715 $1.27 $23,768
Sale
Common Stock 8,858 $6.36 $56,372
Option
Stock Option (Right to Buy) 8,858 $1.27 $11,250
Option
Common Stock 8,858 $1.27 $11,250
Option
Common Stock 33,510 $1.27 $42,558
Sale
Common Stock 33,510 $6.34 $212,554
Option
Stock Option (Right to Buy) 33,510 $1.27 $42,558
Option
Stock Option (Right to Buy) 31,112 $1.27 $39,512
Option
Common Stock 31,112 $1.27 $39,512
Sale
Common Stock 31,112 $6.41 $199,552
Sale
Common Stock 26,520 $6.73 $178,347
Option
Common Stock 26,520 $1.27 $33,680
Option
Stock Option (Right to Buy) 26,520 $1.27 $33,680
Sale
Common Stock 26,941 $6.95 $187,240
Option
Common Stock 26,941 $1.27 $34,215
Option
Stock Option (Right to Buy) 26,941 $1.27 $34,215
Option
Common Stock 73,059 $1.27 $92,785
Sale
Common Stock 73,059 $6.8 $496,801
Option
Stock Option (Right to Buy) 73,059 $1.27 $92,785
Option
Common Stock 42,900 $1.27 $54,483
Option
Stock Option (Right to Buy) 42,900 $1.27 $54,483
Sale
Common Stock 42,900 $5.31 $227,799
Sale
Common Stock 57,100 $6.16 $351,736
Option
Stock Option (Right to Buy) 57,100 $1.27 $72,517
Option
Common Stock 57,100 $1.27 $72,517
Sale
Common Stock 43,896 $4.58 $201,044
Option
Stock option (right to buy) 78,740 $1.27 $100,000
Option
Common Stock 78,740 $1.27 $100,000

Silverback Therapeutics key executives

Silverback Therapeutics, Inc. executives and other stock owners filed with the SEC: